Evinacumab Approval Adds a New Option for Homozygous Familial Hypercholesterolemia With a Hefty Price Tag. Kuehn BM. Circulation 2021;143:2494-2496.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kuehn BM. Evinacumab Approval Adds a New Option for Homozygous Familial Hypercholesterolemia With a Hefty Price Tag. Circulation 2021;143:2494-2496.
PMID: 34152800